These observations may imply that through the intertwined nature of GBM cellular circuitry, the mechanism of action of this combination can counteract the upregulation of DARS and RPS3A and may suggest interactions that can lead to improved therapeutic outcomes. This evidence concerns the gene DARS1 and glioblastoma.